Skip to main content

391 G (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)

Pill with imprint 391 G is Purple, Elliptical/Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Global Pharmaceuticals.

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 391 G

Carbidopa and Levodopa Extended Release

391 G
50 mg / 200 mg
13.00 mm
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Global Pharmaceuticals
National Drug Code (NDC)
00115-3911 (Discontinued)
Inactive Ingredients
hydroxypropyl cellulose, magnesium stearate, FD&C Blue No. 2, FD&C Red No. 40

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "391 G"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.